CIUSSS Capitale nationale logo

Publications

Export 111 results:
Filtres: Author is J-P Julien  [Enlever les filtres]
2008
Millecamps S, J-P Julien. [Dysfunction of axonal transport in neuropathies and motor neuron diseases]. Med Sci (Paris). 2008;24(1):65-71.
Eriksson KS, Zhang S, Lin L, Larivière RC, J-P Julien, Mignot E. The type III neurofilament peripherin is expressed in the tuberomammillary neurons of the mouse. BMC Neurosci. 2008;9:26.
Urushitani M, Ezzi SA, Matsuo A, Tooyama I, J-P Julien. The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS. FASEB J. 2008;22(7):2476-87.
Dequen F, Bomont P, Gowing G, Cleveland DW, J-P Julien. Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1. J Neurochem. 2008;107(1):253-64.
Barrette B, Hébert M-, Filali M, Lafortune K, Vallières N, Gowing G, J-P Julien, Lacroix S. Requirement of myeloid cells for axon regeneration. J Neurosci. 2008;28(38):9363-76.
Gowing G, Philips T, Van Wijmeersch B, Audet J-, Dewil M, Van Den Bosch L, Billiau AD, Robberecht W, J-P Julien. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase. J Neurosci. 2008;28(41):10234-44.
Gros-Louis F, Kriz J, Kabashi E, McDearmid J, Millecamps S, Urushitani M, Lin L, Dion P, Zhu Q, Drapeau P, J-P Julien, Rouleau GA. Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish. Hum Mol Genet. 2008;17(17):2691-702.
2007
Haenggeli C, J-P Julien, R Mosley L, Perez N, Dhar A, Gendelman HE, Rothstein JD. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS. Neurobiol Dis. 2007;26(1):146-52.
Urushitani M, Ezzi SA, J-P Julien. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2007;104(7):2495-500.
Ezzi SA, Urushitani M, J-P Julien. Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J Neurochem. 2007;102(1):170-8.
Barry DM, Millecamps S, J-P Julien, Garcia ML. New movements in neurofilament transport, turnover and disease. Exp Cell Res. 2007;313(10):2110-20.
J-P Julien. ALS: astrocytes move in as deadly neighbors. Nat Neurosci. 2007;10(5):535-7.
Millecamps S, Gowing G, Corti O, Mallet J, J-P Julien. Conditional NF-L transgene expression in mice for in vivo analysis of turnover and transport rate of neurofilaments. J Neurosci. 2007;27(18):4947-56.
Galarneau H, Villeneuve J, Gowing G, J-P Julien, Vallières L. Increased glioma growth in mice depleted of macrophages. Cancer Res. 2007;67(18):8874-81.
Zhai J, Lin H, J-P Julien, Schlaepfer WW. Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot-Marie-Tooth disease-linked mutations in NFL and HSPB1. Hum Mol Genet. 2007;16(24):3103-16.
Barclay M, Noakes PG, Ryan AF, J-P Julien, Housley GD. Neuronal expression of peripherin, a type III intermediate filament protein, in the mouse hindbrain. Histochem Cell Biol. 2007;128(6):541-50.
J-P Julien, Kriz J. Chapter 6 Animal models of motor neuron death. Handb Clin Neurol. 2007;82:121-38.

Financement / Soutien / Partenaires

logo FRQ-S logo ctrn logo fci logo cihr irsc logo nserc logo MESISentinelle nord